KaloBios

A patient with a surgical mask looks out a window

Research

Humanigen drug shows early promise in COVID-19

Treatment with Humanigen's anti-GM-CSF drug helped a small group of critically ill COVID-19 patients recover after a median of five days in a study.

Angus Liu Jun 17, 2020 8:30am

Bull statue

KaloBios emerges from bankruptcy, raises $14M in recap

Jul 1, 2016 7:00am

Please don't hate us; KaloBios’ new CEO takes drug pricing oath

Apr 11, 2016 6:51am